At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
The graduating cohort comprised seven batches across five specialized programs
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
